Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Heidler

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neurology and Therapy|July 3, 2026
Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal StudyAvinash M Suntah, Michael Hecker, Bassel Barhoum, et al.
Journal of Clinical Medicine|August 26, 2023
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple SclerosisJulia Baldt, Niklas Frahm, Michael Hecker, et al.
Scientific Reports|May 28, 2024
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosisKatja Burian, Felicita Heidler, Niklas Frahm, et al.
Therapeutic Advances in Neurological Disorders|October 16, 2024
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacyJanina Meißner, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Drug Safety|April 3, 2023
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancyMarie-Celine Haker, Niklas Frahm, Michael Hecker, et al.
Journal of Clinical Medicine|April 26, 2025
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 PandemicFelicita Heidler, Michael Hecker, Niklas Frahm, et al.
Frontiers in Pharmacology|August 29, 2022
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databasesMichael Hecker, Niklas Frahm, Paula Bachmann, et al.
CNS Neuroscience & Therapeutics|July 10, 2026
Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple SclerosisPegah Mashhadiakbar, Michael Hecker, Niklas Frahm, et al.
Journal of Neurology|October 21, 2025
Whole brain volume loss is associated with a short-term disability progression in relapse-activity free multiple sclerosisRoland Opfer, Lothar Spies, Julia Krüger, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neurology and Therapy|July 3, 2026
Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal StudyAvinash M Suntah, Michael Hecker, Bassel Barhoum, et al.
Journal of Clinical Medicine|August 26, 2023
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple SclerosisJulia Baldt, Niklas Frahm, Michael Hecker, et al.
Scientific Reports|May 28, 2024
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosisKatja Burian, Felicita Heidler, Niklas Frahm, et al.
Therapeutic Advances in Neurological Disorders|October 16, 2024
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacyJanina Meißner, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Drug Safety|April 3, 2023
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancyMarie-Celine Haker, Niklas Frahm, Michael Hecker, et al.
Journal of Clinical Medicine|April 26, 2025
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 PandemicFelicita Heidler, Michael Hecker, Niklas Frahm, et al.
Frontiers in Pharmacology|August 29, 2022
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databasesMichael Hecker, Niklas Frahm, Paula Bachmann, et al.
CNS Neuroscience & Therapeutics|July 10, 2026
Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple SclerosisPegah Mashhadiakbar, Michael Hecker, Niklas Frahm, et al.
Journal of Neurology|October 21, 2025
Whole brain volume loss is associated with a short-term disability progression in relapse-activity free multiple sclerosisRoland Opfer, Lothar Spies, Julia Krüger, et al.
Pageof 2